Risk factors
Ensysce Biosciences (ENSC) risk factors
Item 1A of every Ensysce Biosciences, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors42 risks1 dropped1 reworded
The company regained compliance with Nasdaq equity and bid price requirements, leading to the removal of delisting risk.
Filed Mar 30, 2026 - FY2024 10-K risk factors43 risks
Clinical-stage pharmaceutical company with no revenue, relying heavily on financing and government grants to survive.
Filed Mar 10, 2025